At What Point Would I Need Medication For Type 2 Diabetes?

Medication For Type 2 Diabetes 

If you’re diagnosed with type 2 diabetes, the first resource for managing your diabetes is your primary care provider. Your doctor can help you make informed decisions about diabetes medication, but you should also coordinate with a dietitian, pharmacist, and certified diabetes care and education specialist. Diabetes education should be provided at the time of diagnosis and periodically throughout your treatment. 


Metformin is a type 2 diabetes drug that works to lower blood sugar levels. This drug works by inhibiting the production of the hormone insulin. This hormone helps the body control blood sugar levels by instructing the muscles, fat cells, and liver to remove excess sugar from the blood. Metformin is an excellent alternative to insulin for treating type 2 diabetes. 


If you have type 2 diabetes, you will probably need to start taking medication for your condition. This type of medication can help your body respond better to insulin, and can also reduce your blood sugar levels. Some medications work by increasing the body’s sensitivity to insulin, while others work by enhancing the effects of hormones. One of the most common medications for type 2 diabetes is metformin. This drug belongs to a class of drugs called “biguanides,” and it works by reducing glucose production in the liver, which allows the body to use glucose more efficiently. 

Glucagon-like peptide-1 receptor agonists 

Glucagon-like peptide-I receptor agonists are medications that act on glucagon receptors to reduce blood glucose. They have several positive effects on blood glucose, including cardiovascular safety. They can be used alone or in combination with basal insulin. 

SGLT2 inhibitors 

Despite some controversy, there is no evidence that SGLT2 inhibitors for type 2 diabetics are effective. These drugs reduce the risk of cardiovascular events and have been shown to reduce cardiovascular deaths and MACE. A scientific symposium organized by the National Kidney Foundation evaluated the benefits and risks of SGLT2 inhibitors in both cardiovascular disease and type 2 diabetes (T2DM). 

Glucagon-like peptide-2 (SGLT2) inhibitors 

Glucagon-like peptide 2 (SGLT2) inhibitors are a class of drugs that inhibit the action of glucagon. They decrease plasma glucose levels by blocking the activity of SGLT2 and inhibit proximal tubule glucose reabsorption. Ultimately, this leads to improved b-cell function, reduced weight, and improved sodium excretion. They also have antihypertensive and natriuretic effects. 

Glucagon-like peptide-1 (GLP-1) receptor agonists 

GLP-1 receptor agonists are medications that increase the production of GLP-1 in the pancreas. These hormones help maintain the body’s normal blood glucose levels. There are several GLP-1 receptor agonists approved by the US Food and Drug Administration (FDA) for use in patients with type 2 diabetes. They come in various formulations and can be used alone or in combination with basal insulin to treat diabetes. 

Glucagon-like peptide-2 (GLP-2) receptor agonists 

As the prevalence of type 2 diabetes rises in the world, a new class of drugs has emerged to help treat this condition. These glucagon-like peptide (GLP) receptor agonists are a promising option. They work by increasing the secretion of insulin by the pancreas, reducing blood glucose, and promoting weight loss. These drugs could be the key to breaking the cycle of sequential medication additions that has plagued patients with type 2 diabetes.